STOCK TITAN

UiPath, Inc. (PATH) SEC Filings, Oct 8-15, 2025

PATH NYSE

Welcome to our dedicated page for UiPath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

UiPath SEC filings document material events for an enterprise automation software company listed under PATH. Recent Form 8-K disclosures cover operating and financial results, executive leadership and compensation arrangements, annual meeting voting outcomes, and governance matters including director elections, advisory compensation votes, and auditor ratification.

The filings also record capital-structure subjects tied to UiPath's Class A and Class B common stock, including stockholder trading-plan disclosures. These records frame PATH's public-company reporting around results releases, board and officer matters, stockholder votes, and equity ownership structure.

Rhea-AI Summary

UiPath (PATH) filed a Form 4 reporting that its Chief Accounting Officer sold Class A common stock pursuant to a Rule 10b5-1 plan. The officer sold 10,000 shares on 10/14/2025 at an average price of $16.5351 (price range $16.1200–$16.9000) and 10,000 shares on 10/15/2025 at an average price of $16.6801 (price range $16.2400–$17.1100).

Following these transactions, the reporting person beneficially owned 232,776 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) filed a Form 144 notice for a proposed sale of restricted securities by an affiliate. The filing lists 10,000 common shares to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $164,800, on or about 10/15/2025 on the NYSE. Shares outstanding were 453,568,899.

The shares were acquired as Restricted Stock Units from the issuer on 01/01/2024. The notice also reports recent activity under a 10b5-1 framework: on 10/14/2025, 10,000 shares sold for $165,351, and on 10/13/2025, 10,000 shares sold for $170,056.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

UiPath (PATH) insider BRAD C BRUBAKER filed a Form 144 notice to sell company stock. The filing lists 27,580 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $454,518.40. The approximate sale date is 10/15/2025, and the shares trade on the NYSE.

The shares to be sold were acquired on 07/01/2023 via restricted stock units. As context, shares outstanding were 453,568,899. The notice also lists recent plan-driven sales: 66,665 shares on 10/06/2025 for $999,985.58 and 16,083 shares on 09/30/2025 for $241,262.69, each under a Rule 10b5-1 trading plan.

Form 144 is a notice of proposed sales by an affiliate and does not itself execute the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

UiPath (PATH) COO & CFO Ashim Gupta reported insider transactions on 10/09/2025. He exercised 148,009 stock options at $0.7533 per share and executed open‑market sales under a Rule 10b5‑1 trading plan.

Sales were reported in three blocks: 181,745 shares at an average price of $17.0122 (range $16.2800–$17.2700), 32,144 shares at $17.7403 (range $17.2800–$18.2700), and 26,985 shares at $18.5263 (range $18.2800–$18.7300). Following these transactions, he directly owned 696,117 Class A shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) CEO and Chairman Daniel Dines reported open‑market sales under a Rule 10b5‑1 plan. He sold 122,734 Class A shares on 10/13/2025 at an average price of $17.0604 (price range $16.8700–$17.2900) and 122,734 shares on 10/14/2025 at an average price of $16.3347 (range $16.0700–$16.8100).

Following these transactions, reported holdings include 245,468 Class A shares held indirectly via Ice Vulcan Holding Limited, 29,918,585 Class A shares held directly, and 240,000 Class A shares held indirectly by spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) disclosed a Form 4 showing its Chief Accounting Officer sold 10,000 shares of Class A common stock on 10/13/2025 at an average price of $17.0056 under a Rule 10b5-1 trading plan.

Following the sale, the officer directly owned 252,776 shares. The reported trades occurred within a price range of $16.6400 to $17.3400.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath, Inc. (PATH) reported an insider transaction by its CEO and Chairman, who is also a Director and 10% Owner. On 10/10/2025, the reporting person sold 122,734 shares of Class A Common Stock (Transaction Code S) at an average price of $18.3721, executed under a qualified Rule 10b5-1 selling plan. The price range for the sale was $18.1600 to $18.5900.

Following the transaction, the filing lists beneficial ownership positions as: 29,918,585 shares direct; 490,936 shares indirect (see footnote regarding Ice Vulcan Holding Limited); and 240,000 shares indirect by spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
insider
-
Rhea-AI Summary

UiPath insider sale reported by CEO and Chairman Daniel Dines. The filing shows that on 10/09/2025 Mr. Dines (reporting person) caused the sale of multiple blocks of Class A Common Stock, including a discrete disposal of 29,918,585 shares and a separate sale of 122,734 shares at an average price range of $16.21 to $16.98 (reported price point $16.5743). The Form 4 states the trades were executed under a Rule 10b5-1 selling plan. After the reported transactions, Mr. Dines retains indirect beneficial ownership of 613,670 shares and a separate indirect holding of 240,000 shares held by his spouse via related entities, with voting and investment power retained through Ice Vulcan entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
insider
-
Rhea-AI Summary

UiPath, Inc. reported a proposed insider sale under Rule 144 for 240,874 common shares with an aggregate market value of $3,752,816.92. The filing shows the shares are to be sold on or about 10/09/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The position being sold was acquired in two tranches: 148,009 shares from an exercise of stock options on 10/09/2025 (paid in cash) and 92,865 shares from restricted stock units on 01/01/2024.

The filer certifies there were no sales by the same person in the past three months and affirms no undisclosed material adverse information is known. The form is marked as a LIVE filing and includes broker and share-outstanding details: 453,568,899 shares outstanding were reported in the table.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
other
Rhea-AI Summary

Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported a sale of 122,734 shares of Class A common stock executed on 10/08/2025 under a qualified Rule 10b5-1 selling plan. The filing lists a reported price figure of $14.8901 and a disclosed transaction price range from $14.7700 to $15.0400. After the reported transactions the document shows 736,404 shares beneficially owned in an indirect form through Ice Vulcan Holding Limited, an entity ultimately owned by Mr. Dines; the filing states he retains sole voting and investment power over those shares. The sale was executed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many UiPath (PATH) SEC filings are available on StockTitan?

StockTitan tracks 187 SEC filings for UiPath (PATH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UiPath (PATH)?

The most recent SEC filing for UiPath (PATH) was filed on October 15, 2025.